🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 13 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/01/2023 | 274,95 | 279,14 | 272,94 | 276,17 | +0,75% | 2,25% | 341.600 |
| 05/01/2023 | 274,11 | 275,52 | 270,60 | 274,12 | +0,47% | 1,79% | 501.800 |
| 04/01/2023 | 272,47 | 273,89 | 270,17 | 272,83 | -0,18% | 1,37% | 343.300 |
| 03/01/2023 | 276,26 | 277,67 | 272,10 | 273,32 | -1,72% | 2,02% | 496.400 |
| 30/12/2022 | 274,97 | 278,50 | 273,57 | 278,09 | +0,76% | 1,79% | 275.700 |
| 29/12/2022 | 274,36 | 277,48 | 272,90 | 275,99 | +0,96% | 1,67% | 257.900 |
| 28/12/2022 | 273,89 | 276,32 | 271,73 | 273,36 | -0,14% | 1,68% | 211.200 |
| 27/12/2022 | 280,09 | 280,88 | 271,72 | 273,75 | -1,82% | 3,27% | 213.100 |
| 23/12/2022 | 277,72 | 279,17 | 275,33 | 278,82 | +0,57% | 1,38% | 245.800 |
| 22/12/2022 | 274,46 | 277,50 | 272,32 | 277,25 | +1,28% | 1,89% | 194.500 |
| 21/12/2022 | 273,32 | 278,25 | 271,33 | 273,75 | -0,11% | 2,53% | 364.000 |
| 20/12/2022 | 272,03 | 274,32 | 269,20 | 274,05 | +0,88% | 1,88% | 387.800 |
| 19/12/2022 | 278,39 | 281,40 | 267,45 | 271,65 | -2,62% | 5,01% | 458.700 |
| 16/12/2022 | 274,70 | 280,79 | 273,37 | 278,96 | +1,13% | 2,70% | 1.008.000 |
| 15/12/2022 | 277,10 | 277,49 | 270,90 | 275,85 | -0,31% | 2,38% | 352.700 |
| 14/12/2022 | 275,00 | 279,80 | 274,20 | 276,71 | +0,10% | 2,04% | 444.400 |
| 13/12/2022 | 280,02 | 280,74 | 275,88 | 276,43 | -1,28% | 1,74% | 290.500 |
| 12/12/2022 | 279,31 | 280,57 | 276,66 | 280,01 | -0,15% | 1,40% | 229.700 |
| 09/12/2022 | 278,14 | 283,09 | 277,73 | 280,43 | +0,20% | 1,93% | 564.300 |
| 08/12/2022 | 276,19 | 281,32 | 275,97 | 279,88 | +1,01% | 1,94% | 408.100 |
| 07/12/2022 | 275,90 | 278,97 | 272,37 | 277,08 | +0,17% | 2,39% | 316.500 |
| 06/12/2022 | 275,00 | 277,96 | 269,99 | 276,60 | +1,05% | 2,90% | 483.900 |
| 05/12/2022 | 271,40 | 274,04 | 264,84 | 273,72 | -1,73% | 3,39% | 606.400 |
| 02/12/2022 | 273,91 | 282,22 | 273,91 | 278,55 | +1,07% | 3,03% | 252.600 |
| 01/12/2022 | 279,89 | 280,43 | 274,63 | 275,61 | -1,53% | 2,07% | 267.700 |
| 30/11/2022 | 272,33 | 280,27 | 271,30 | 279,89 | +3,27% | 3,29% | 562.700 |
| 29/11/2022 | 270,50 | 271,53 | 268,60 | 271,03 | +0,13% | 1,08% | 240.100 |
| 28/11/2022 | 267,41 | 271,88 | 267,41 | 270,69 | +0,98% | 1,67% | 297.000 |
| 25/11/2022 | 267,59 | 268,45 | 266,23 | 268,07 | +0,45% | 0,83% | 78.400 |
| 23/11/2022 | 270,43 | 271,92 | 266,48 | 266,86 | -1,50% | 2,01% | 191.800 |